Recent Articles

ZTS: A Market Leader That Looks Ready to Soar Higher

Zoetis is a dominant market leader with decided scale advantages over its peers, operating in an industry with clear macro tailwinds. ZTS stock is a good buy at this level. More 

Trade of the Day: Zoetis (ZTS)

I want to clue you in on one of the equities I have a position in my Trader's Advantage service. More 

9 Pharmaceutical Stocks to Buy Now

This week, nine pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

10 Pharmaceutical Stocks to Buy Now

The grades of 10 pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating. More 

45 Blue-Chip Dividend Stocks That Increased Payouts in Q4 2014

Dividend stocks in just about every sector thrilled investors with meaningful payout raises in Q4. Here's a look at 45 of the biggest blue chips to up the ante. More 

Dow Stars, Biotech Lead 13 Dividend Stocks Increasing Payouts

The central bank’s “patience” stance when it comes to future interest rate hikes was a present to the bulls, and the result was a week of pre-holiday stock market revelry. Here are 13 stocks increasing dividends. More 

5 Overhyped Stocks to Sell Now

Zoetis, Apple, Yahoo!, and a couple of other overhyped stocks are ripe for pullbacks. Don't wait for the meltdown to start before heading for the exit. More